Search

Search Constraints

You searched for: Author/Creator Blohmer, Jens-Uwe

Search Results

1. 2022-LBA-607-ESGO How long do our patients stay fasting? a multicentric prospective survey on the perioperative fasting in 924 Patients conducted by the JAGO study group. (27th October 2022)

2. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Issue 8 (August 2021)

3. Corrigendum to 'Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients [European Journal of Cancer 163 (2022) 128–139]. (October 2022)

4. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03. Issue 3 (March 2022)

5. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03. Issue 3 (9th March 2022)

6. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

7. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

8. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

9. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)

10. Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Issue 2 (16th November 2020)